Publication Information

{'id': 'https://openalex.org/W2164642859', 'doi': 'https://doi.org/10.1111/jacf.12128', 'title': 'Revisiting “The Fruits of Genomics”: How the Biopharma Industry Lost But Is Now Regaining its Productivity', 'display_name': 'Revisiting “The Fruits of Genomics”: How the Biopharma Industry Lost But Is Now Regaining its Productivity', 'publication_year': 2015, 'publication_date': '2015-09-01', 'ids': {'openalex': 'https://openalex.org/W2164642859', 'doi': 'https://doi.org/10.1111/jacf.12128', 'mag': '2164642859'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/jacf.12128', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S144611220', 'display_name': 'Journal of Applied Corporate Finance', 'issn_l': '1078-1196', 'issn': ['1078-1196'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5081521056', 'display_name': 'A. R. Leheny', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210102664', 'display_name': 'Enzo Life Sciences (United States)', 'ror': 'https://ror.org/01d7h6313', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210102664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'A. Rachel Leheny', 'raw_affiliation_strings': ['RACHEL LEHENY, PhD, and ERIC ROBERTS are co-founders of Valence Life Sciences and Caxton Advantage Life Sciences, late-stage venture funds. Before becoming venture capitalists, they worked together at Lehman Brothers where they lead the life sciences banking (Eric) and research (Rachel) teams. Prior to that, they ran the life sciences efforts at UBS. Rachel started her carreer at Hambrecht & Quist, and Eric started his at Dillon Read. Rachel holds at doctorate in chemistry from Columbia University and a AB in chemistry from Harvard University, and Eric holds a BS from the Wharton School of Business.'], 'affiliations': [{'raw_affiliation_string': 'RACHEL LEHENY, PhD, and ERIC ROBERTS are co-founders of Valence Life Sciences and Caxton Advantage Life Sciences, late-stage venture funds. Before becoming venture capitalists, they worked together at Lehman Brothers where they lead the life sciences banking (Eric) and research (Rachel) teams. Prior to that, they ran the life sciences efforts at UBS. Rachel started her carreer at Hambrecht & Quist, and Eric started his at Dillon Read. Rachel holds at doctorate in chemistry from Columbia University and a AB in chemistry from Harvard University, and Eric holds a BS from the Wharton School of Business.', 'institution_ids': ['https://openalex.org/I4210102664']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5066174263', 'display_name': 'Eric W. Roberts', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210102664', 'display_name': 'Enzo Life Sciences (United States)', 'ror': 'https://ror.org/01d7h6313', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210102664']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Eric W. Roberts', 'raw_affiliation_strings': ['RACHEL LEHENY, PhD, and ERIC ROBERTS are co-founders of Valence Life Sciences and Caxton Advantage Life Sciences, late-stage venture funds. Before becoming venture capitalists, they worked together at Lehman Brothers where they lead the life sciences banking (Eric) and research (Rachel) teams. Prior to that, they ran the life sciences efforts at UBS. Rachel started her carreer at Hambrecht & Quist, and Eric started his at Dillon Read. Rachel holds at doctorate in chemistry from Columbia University and a AB in chemistry from Harvard University, and Eric holds a BS from the Wharton School of Business.'], 'affiliations': [{'raw_affiliation_string': 'RACHEL LEHENY, PhD, and ERIC ROBERTS are co-founders of Valence Life Sciences and Caxton Advantage Life Sciences, late-stage venture funds. Before becoming venture capitalists, they worked together at Lehman Brothers where they lead the life sciences banking (Eric) and research (Rachel) teams. Prior to that, they ran the life sciences efforts at UBS. Rachel started her carreer at Hambrecht & Quist, and Eric started his at Dillon Read. Rachel holds at doctorate in chemistry from Columbia University and a AB in chemistry from Harvard University, and Eric holds a BS from the Wharton School of Business.', 'institution_ids': ['https://openalex.org/I4210102664']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 2630, 'currency': 'USD', 'value_usd': 2630, 'provenance': 'doaj'}, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 2, 'citation_normalized_percentile': {'value': 0.672485, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 73, 'max': 76}, 'biblio': {'volume': '27', 'issue': '3', 'first_page': '49', 'last_page': '60'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T14293', 'display_name': 'Biotechnology and Related Fields', 'score': 0.9911, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T14293', 'display_name': 'Biotechnology and Related Fields', 'score': 0.9911, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11903', 'display_name': 'Private Equity and Venture Capital', 'score': 0.9908, 'subfield': {'id': 'https://openalex.org/subfields/1402', 'display_name': 'Accounting'}, 'field': {'id': 'https://openalex.org/fields/14', 'display_name': 'Business, Management and Accounting'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}, {'id': 'https://openalex.org/T12722', 'display_name': 'Innovation Policy and R&D', 'score': 0.9437, 'subfield': {'id': 'https://openalex.org/subfields/2002', 'display_name': 'Economics and Econometrics'}, 'field': {'id': 'https://openalex.org/fields/20', 'display_name': 'Economics, Econometrics and Finance'}, 'domain': {'id': 'https://openalex.org/domains/2', 'display_name': 'Social Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C21279758', 'wikidata': 'https://www.wikidata.org/wiki/Q219409', 'display_name': 'Venture capital', 'level': 2, 'score': 0.55333203}, {'id': 'https://openalex.org/C187736073', 'wikidata': 'https://www.wikidata.org/wiki/Q2920921', 'display_name': 'Management', 'level': 1, 'score': 0.552722}, {'id': 'https://openalex.org/C204983608', 'wikidata': 'https://www.wikidata.org/wiki/Q2111958', 'display_name': 'Productivity', 'level': 2, 'score': 0.4131058}, {'id': 'https://openalex.org/C17744445', 'wikidata': 'https://www.wikidata.org/wiki/Q36442', 'display_name': 'Political science', 'level': 0, 'score': 0.33134264}, {'id': 'https://openalex.org/C199539241', 'wikidata': 'https://www.wikidata.org/wiki/Q7748', 'display_name': 'Law', 'level': 1, 'score': 0.13892177}, {'id': 'https://openalex.org/C162324750', 'wikidata': 'https://www.wikidata.org/wiki/Q8134', 'display_name': 'Economics', 'level': 0, 'score': 0.13072467}, {'id': 'https://openalex.org/C139719470', 'wikidata': 'https://www.wikidata.org/wiki/Q39680', 'display_name': 'Macroeconomics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1111/jacf.12128', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S144611220', 'display_name': 'Journal of Applied Corporate Finance', 'issn_l': '1078-1196', 'issn': ['1078-1196'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Industry, innovation and infrastructure', 'id': 'https://metadata.un.org/sdg/9', 'score': 0.41}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W617680363', 'https://openalex.org/W4247813191', 'https://openalex.org/W4237617349', 'https://openalex.org/W4233696877', 'https://openalex.org/W4230321318', 'https://openalex.org/W4205213987', 'https://openalex.org/W409056671', 'https://openalex.org/W2801588038', 'https://openalex.org/W2141619635', 'https://openalex.org/W1975634507'], 'abstract_inverted_index': {'Journal': [0], 'of': [1, 15, 42, 128, 149, 235, 257, 343, 364, 450, 486, 496, 509, 520], 'Applied': [2], 'Corporate': [3], 'FinanceVolume': [4], '27,': [5], 'Issue': [6], '3': [7], 'p.': [8], '49-60': [9, 538], 'Original': [10], 'Articles': [11], 'Revisiting': [12], '"The': [13], 'Fruits': [14], 'Genomics":': [16], 'How': [17], 'the': [18, 67, 81, 125, 174, 188, 232, 282, 296, 340, 389, 403, 447, 464, 502, 512], 'Biopharma': [19], 'Industry': [20], 'Lost': [21], 'But': [22], 'Is': [23], 'Now': [24], 'Regaining': [25], 'its': [26], 'Productivity': [27], 'A.': [28, 31, 243, 246], 'Rachel': [29, 32, 87, 102, 194, 209, 244, 247, 302, 317, 409, 424], 'Leheny,': [30, 245], 'Leheny': [33, 248], 'RACHEL': [34, 141, 249, 356], 'LEHENY,': [35, 142, 250, 357], 'PhD,': [36, 143, 251, 358], 'and': [37, 46, 72, 95, 111, 119, 144, 153, 179, 202, 218, 226, 252, 261, 287, 310, 326, 334, 359, 368, 394, 417, 433, 441, 484, 488, 500, 507, 526], 'ERIC': [38, 145, 253, 360], 'ROBERTS': [39, 146, 254, 361], 'are': [40, 147, 255, 362], 'co-founders': [41, 148, 256, 363], 'Valence': [43, 150, 258, 365], 'Life': [44, 49, 151, 156, 259, 264, 366, 371], 'Sciences': [45, 152, 260, 367], 'Caxton': [47, 154, 262, 369], 'Advantage': [48, 155, 263, 370], 'Sciences,': [50, 157, 265, 372], 'late-stage': [51, 158, 266, 373], 'venture': [52, 56, 159, 163, 267, 271, 374, 378], 'funds.': [53, 160, 268, 375], 'Before': [54, 161, 269, 376], 'becoming': [55, 162, 270, 377], 'capitalists,': [57, 164, 272, 379], 'they': [58, 65, 79, 165, 172, 186, 273, 280, 294, 380, 387, 401], 'worked': [59, 166, 274, 381], 'together': [60, 167, 275, 382], 'at': [61, 85, 91, 99, 104, 168, 192, 198, 206, 211, 276, 300, 306, 314, 319, 383, 407, 413, 421, 426], 'Lehman': [62, 169, 277, 384], 'Brothers': [63, 170, 278, 385], 'where': [64, 171, 279, 386], 'lead': [66, 173, 281, 388], 'life': [68, 82, 175, 189, 283, 297, 390, 404], 'sciences': [69, 83, 176, 190, 284, 298, 391, 405], 'banking': [70, 177, 285, 392], '(Eric)': [71, 178, 286, 393], 'research': [73, 180, 288, 395], '(Rachel)': [74, 181, 289, 396], 'teams.': [75, 182, 290, 397], 'Prior': [76, 183, 291, 398], 'to': [77, 184, 292, 399, 470, 492, 515], 'that,': [78, 185, 293, 400], 'ran': [80, 187, 295, 402], 'efforts': [84, 191, 299, 406], 'UBS.': [86, 193, 301, 408], 'started': [88, 97, 195, 204, 303, 312, 410, 419], 'her': [89, 196, 304, 411], 'carreer': [90, 197, 305, 412], 'Hambrecht': [92, 199, 307, 414], '&': [93, 200, 308, 415], 'Quist,': [94, 201, 309, 416], 'Eric': [96, 120, 138, 203, 227, 311, 335, 353, 418, 442], 'his': [98, 205, 313, 420], 'Dillon': [100, 207, 315, 422], 'Read.': [101, 208, 316, 423], 'holds': [103, 121, 210, 228, 318, 336, 425, 443], 'doctorate': [105, 212, 320, 427], 'in': [106, 114, 213, 221, 321, 329, 428, 436], 'chemistry': [107, 115, 214, 222, 322, 330, 429, 437], 'from': [108, 116, 124, 215, 223, 231, 323, 331, 339, 430, 438, 446], 'Columbia': [109, 216, 324, 431], 'University': [110, 217, 325, 432], 'a': [112, 122, 219, 229, 327, 337, 434, 444, 517, 532], 'AB': [113, 220, 328, 435], 'Harvard': [117, 224, 332, 439], 'University,': [118, 225, 333, 440], 'BS': [123, 230, 338, 445], 'Wharton': [126, 233, 341, 448], 'School': [127, 234, 342, 449], 'Business.Search': [129, 236, 344, 451], 'for': [130, 237, 345, 452], 'more': [131, 238, 346, 453], 'papers': [132, 239, 347, 454], 'by': [133, 240, 348, 455], 'this': [134, 241, 349, 456, 521], 'authorEric': [135, 350], 'W.': [136, 139, 351, 354], 'Roberts,': [137, 352], 'Roberts': [140, 355], 'author': [242, 457], 'First': [458], 'published:': [459], '16': [460], 'October': [461], '2015': [462], 'https://doi.org/10.1111/jacf.12128Read': [463], 'full': [465, 476], 'textAboutPDF': [466], 'ToolsRequest': [467], 'permissionExport': [468], 'citationAdd': [469], 'favoritesTrack': [471], 'citation': [472], 'ShareShare': [473], 'Give': [474], 'accessShare': [475, 478], 'text': [477], 'full-text': [479, 494, 518], 'accessPlease': [480], 'review': [481], 'our': [482], 'Terms': [483, 506], 'Conditions': [485, 508], 'Use': [487], 'check': [489], 'box': [490], 'below': [491, 514], 'share': [493, 516], 'version': [495, 519], 'article.I': [497], 'have': [498], 'read': [499], 'accept': [501], 'Wiley': [503], 'Online': [504], 'Library': [505], 'UseShareable': [510], 'LinkUse': [511], 'link': [513], 'article': [522], 'with': [523], 'your': [524], 'friends': [525], 'colleagues.': [527], 'Learn': [528], 'more.Copy': [529], 'URL': [530], 'Share': [531], 'linkShare': [533], 'onEmailFacebookTwitterLinkedInRedditWechat': [534], 'Volume27,': [535], 'Issue3Summer': [536], '2015Pages': [537], 'RelatedInformation': [539]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2164642859', 'counts_by_year': [{'year': 2022, 'cited_by_count': 1}, {'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-12-15T23:18:39.844836', 'created_date': '2016-06-24'}